UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013812
Receipt number R000016120
Scientific Title Efficacy and safety of sitafloxacin (STFX) in tonsillar abcess; prospective study in outpatient setting.
Date of disclosure of the study information 2014/04/25
Last modified on 2019/03/29 11:20:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of sitafloxacin (STFX) in tonsillar abcess; prospective study in outpatient setting.

Acronym

Efficacy and safety of sitafloxacin in tonsillar abcess.

Scientific Title

Efficacy and safety of sitafloxacin (STFX) in tonsillar abcess; prospective study in outpatient setting.

Scientific Title:Acronym

Efficacy and safety of sitafloxacin in tonsillar abcess.

Region

Japan


Condition

Condition

peritonsillar abcess

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of sitafloxacin in peritonsiller abcess.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

subjective symptom, objective findings, CRP, WBC

Key secondary outcomes

adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

200mg/day of sitafloxacin for 1-2weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who diagnosed peritonsillar abcess.

Key exclusion criteria

Patients who need hospitalization
Allergy for sitafloxacin
pregnant or probable pregnant
renal dysfunction (Ccr<50)
airway stenosis

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsushi Kamijo

Organization

Saitama Medical University

Division name

Otorhinolaryngology, Allergy Center

Zip code


Address

38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan

TEL

049-276-1253

Email

atkamijo@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Kamijo

Organization

Saitama Medical University

Division name

Otorhinolaryngology

Zip code


Address

38 Morohongo, Moroyama-machi, Irum-gun, Saitama, Japan

TEL

049-276-1253

Homepage URL


Email

atkamijo@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Dept Otorhinolaryngology, Saitama Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 09 Month 13 Day

Date of IRB

2012 Year 09 Month 12 Day

Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 25 Day

Last modified on

2019 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016120


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name